GlassScriptPhysician profile
Harold S Minkowitz
NPI 1164506010
$224,394.04
in general payments reported to CMS, 2019-2025
16 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69K · 2020: $49K · 2021: $70K · 2022: $15K · 2023: $7,561 · 2024: $2,668 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $1,053 · Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,717.50 |
| Travel and Lodging | $1,052.98 |
| Food and Beverage | $708.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $98,078.33 | 2019-2022 | |
| Acacia Pharma INC | $51,184.95 | 2021-2022 | |
| Heron Therapeutics, INC. | $32,599.58 | 2019-2021 | |
| Davol INC. | $7,782.50 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $7,343.93 | 2023 | |
| Janssen Research & Development, LLC | $7,257.50 | 2019 | |
| Hikma Pharmaceuticals USA | $5,940.00 | 2025 | |
| Cipla USA INC. | $3,866.11 | 2019 | |
| Eli Lilly and Company | $3,800.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $1,627.98 | 2019 | |
| Pfizer INC. | $1,480.00 | 2021 | |
| Grifols Therapeutics LLC | $1,373.62 | 2019 | |
| Baudax Bio INC. | $1,105.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $470.32 | 2019-2025 | Exparel, Zilretta, Iovera |
| Takeda Pharmaceuticals U.S.A., INC. | $400.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $84.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Minkowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.